Table 3. In-hospital mortality and hospital length of stay analyzed by pre-transcatheter aortic valve replacement tricuspid regurgitation severity.
Variable | Timing | Tricuspid regurgitation severity | P value | ||
---|---|---|---|---|---|
Trace/mild (0–1+) | Moderate (2+) | Severe (3–4+) | |||
All-cause mortality | Pre-TAVR | 4/124 (3.2) | 7/34 (20.6) | 2/16 (12.5) | 0.007 |
Post-TAVR | 7/139 (5.0) | 3/22 (13.6) | 3/13 (23.1) | 0.008 | |
Cardiovascular mortality | Pre-TAVR | 2/124 (1.6) | 5/34 (14.7) | 1/16 (6.3) | 0.027 |
Post-TAVR | 4/140 (2.9) | 1/22 (4.5) | 3/13 (23.1) | 0.003 | |
Median length of hospital stay (days, IQR) | Pre-TAVR | 5 [3–10] | 4 [6–20] | 4 [3–9] | 0.756 |
Post-TAVR | 5 [3–9] | 6 [4–11] | 15 [4–20] | 0.156 |
Variables presented as number (percentage), unless otherwise noted. TAVR, transcatheter aortic valve replacement.